314 related articles for article (PubMed ID: 37200816)
1. The Intricate Notch Signaling Dynamics in Therapeutic Realms of Cancer.
Sen P; Ghosh SS
ACS Pharmacol Transl Sci; 2023 May; 6(5):651-670. PubMed ID: 37200816
[TBL] [Abstract][Full Text] [Related]
2. Notch signaling in breast cancer: From pathway analysis to therapy.
Krishna BM; Jana S; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
Cancer Lett; 2019 Oct; 461():123-131. PubMed ID: 31326555
[TBL] [Abstract][Full Text] [Related]
3. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
4. Targeting notch signaling pathway in cancer: clinical development advances and challenges.
Takebe N; Nguyen D; Yang SX
Pharmacol Ther; 2014 Feb; 141(2):140-9. PubMed ID: 24076266
[TBL] [Abstract][Full Text] [Related]
5. γ-Secretase Inhibitor Potentiates the Activity of Suberoylanilide Hydroxamic Acid by Inhibiting Its Ability to Induce Epithelial to Mesenchymal Transition and Stemness via Notch Pathway Activation in Triple-Negative Breast Cancer Cells.
Sen P; Ghosh SS
ACS Pharmacol Transl Sci; 2023 Oct; 6(10):1396-1415. PubMed ID: 37854616
[TBL] [Abstract][Full Text] [Related]
6. A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma.
Herrera-Rios D; Li G; Khan D; Tsiampali J; Nickel AC; Aretz P; Hewera M; Suwala AK; Jiang T; Steiger HJ; Kamp MA; Muhammad S; Hänggi D; Maciaczyk J; Zhang W; Kahlert UD
Sci Rep; 2020 Oct; 10(1):16218. PubMed ID: 33004830
[TBL] [Abstract][Full Text] [Related]
7. Gamma secretase inhibitors of Notch signaling.
Olsauskas-Kuprys R; Zlobin A; Osipo C
Onco Targets Ther; 2013; 6():943-55. PubMed ID: 23901284
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic antibody targeting of individual Notch receptors.
Wu Y; Cain-Hom C; Choy L; Hagenbeek TJ; de Leon GP; Chen Y; Finkle D; Venook R; Wu X; Ridgway J; Schahin-Reed D; Dow GJ; Shelton A; Stawicki S; Watts RJ; Zhang J; Choy R; Howard P; Kadyk L; Yan M; Zha J; Callahan CA; Hymowitz SG; Siebel CW
Nature; 2010 Apr; 464(7291):1052-7. PubMed ID: 20393564
[TBL] [Abstract][Full Text] [Related]
9. The Notch signaling pathway in desmoid tumor: Recent advances and the therapeutic prospects.
Zheng C; Huang J; Xu G; Li W; Weng X; Zhang S
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166907. PubMed ID: 37793461
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance.
Feng M; Santhanam RK; Xing H; Zhou M; Jia H
Biochem Pharmacol; 2024 Feb; 220():115991. PubMed ID: 38135129
[TBL] [Abstract][Full Text] [Related]
11. The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments.
LaVoie MJ; Selkoe DJ
J Biol Chem; 2003 Sep; 278(36):34427-37. PubMed ID: 12826675
[TBL] [Abstract][Full Text] [Related]
12. The Notch signaling pathway as a mediator of tumor survival.
Capaccione KM; Pine SR
Carcinogenesis; 2013 Jul; 34(7):1420-30. PubMed ID: 23585460
[TBL] [Abstract][Full Text] [Related]
13. The Membrane-Bound Notch Regulator Mnr Supports Notch Cleavage and Signaling Activity in
Nagel AC; Müller D; Zimmermann M; Preiss A
Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827670
[TBL] [Abstract][Full Text] [Related]
14. Notch and its oncogenic activity in human malignancies.
Brzozowa-Zasada M; Piecuch A; Michalski M; Segiet O; Kurek J; Harabin-Słowińska M; Wojnicz R
Eur Surg; 2017; 49(5):199-209. PubMed ID: 29104587
[TBL] [Abstract][Full Text] [Related]
15. Role of Notch and its oncogenic signaling crosstalk in breast cancer.
Guo S; Liu M; Gonzalez-Perez RR
Biochim Biophys Acta; 2011 Apr; 1815(2):197-213. PubMed ID: 21193018
[TBL] [Abstract][Full Text] [Related]
16. Targeting Notch signalling pathway of cancer stem cells.
Venkatesh V; Nataraj R; Thangaraj GS; Karthikeyan M; Gnanasekaran A; Kaginelli SB; Kuppanna G; Kallappa CG; Basalingappa KM
Stem Cell Investig; 2018; 5():5. PubMed ID: 29682512
[TBL] [Abstract][Full Text] [Related]
17. Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and Advances in Clinical Development.
You WK; Schuetz TJ; Lee SH
Mol Cancer Ther; 2023 Jan; 22(1):3-11. PubMed ID: 36223541
[TBL] [Abstract][Full Text] [Related]
18. Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
Wang L; Dai G; Yang J; Wu W; Zhang W
Med Sci Monit; 2018 Jun; 24():4046-4053. PubMed ID: 29899322
[TBL] [Abstract][Full Text] [Related]
19. A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signaling.
Das A; Narayanam MK; Paul S; Mukhnerjee P; Ghosh S; Dastidar DG; Chakrabarty S; Ganguli A; Basu B; Pal M; Chatterji U; Banerjee SK; Karmakar P; Kumar D; Chakrabarti G
J Biol Chem; 2019 Apr; 294(17):6733-6750. PubMed ID: 30824542
[TBL] [Abstract][Full Text] [Related]
20. Jagged1 protein processing in the developing mammalian lens.
Azimi M; Brown NL
Biol Open; 2019 Mar; 8(3):. PubMed ID: 30890522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
